Drug Trial Radar · NCT00216346
Safety and Efficacy Study of Paromomycin to Treat Visceral Leishmaniasis
Last checked: Nov 20, 2026Latest source record: Oct 3, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
667
Actual
Start
Jun 2003
Primary completion
Not stated
Study completion Nov 2004
Sponsor
- Lead sponsor
- PATHAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- World Health Organization
- First posted
- Sep 22, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 5 years, up to 55 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Symptomatic Visceral Leishmaniasis(VL)is fatal; Due to the increasing resistance to standard therapy with antimonials, there is a need for new safe, efficacious, low-cost therapies for the treatment of VL. Paromomycin is an off-patent aminoglycoside antibiotic with anti-leishmaniasis activity. This study will test the safety and efficacy of paromomycin in the treatment of patients with VL in India.
Conditions
- Visceral Leishmaniasis
Interventions
Paromomycin sulfateDrug
Amphotericin BDrug
Primary outcomes
What the sponsor says the trial is designed to measure.
- (1) To compare the safety of injectable paromomycin to amphotericin B when administered in the proposed dosage regimens.
- (2) To compare the efficacy of injectable paromomycin to amphotericin B with regards to final cure rates.
Locations
4 sites in 1 country. Site status is shown where the registry gives one.
Rajendra Memorial Research Institute of Medical Sciences (ICMR)
Agam Kuan, Patna, Bihar, India
Kalazar Research Centre
Brahmpura, Muzaffarpur, Bihar, India
Kalazar Research Centre
Patna, Bihar, India
Kala-azar Medical Research Centre
Rambagh Road Muzaffarpur, Bihar, India
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.